ICD-10: B08.5

Enteroviral vesicular pharyngitis, classified under ICD-10 code B08.5, is characterized by a range of clinical presentations, signs, symptoms, and patient characteristics. Here’s a detailed overview:

Clinical Presentation

• Acute Onset: The condition typically presents suddenly, often following a viral prodrome.
• Vesicular Lesions: Patients may develop vesicular lesions in the oropharynx, which can lead to significant discomfort.

Signs and Symptoms

• Fever: A common initial symptom, often accompanied by chills.
• Sore Throat: Patients frequently report a severe sore throat, which can be debilitating.
• Headache: Many individuals experience headaches, which may vary in intensity.
• Loss of Appetite: Due to pain and discomfort, patients often have a reduced desire to eat.
• Oral Ulcers: The presence of sores or blisters in the mouth and throat is a hallmark of this condition, contributing to pain and difficulty swallowing [9].

Patient Characteristics

• Age Group: Enteroviral vesicular pharyngitis is more prevalent in children, particularly those under the age of 5, but can occur in individuals of any age.
• Seasonality: The condition is often seen in late summer and early fall, aligning with the peak season for enteroviral infections.
• Infectious Etiology: The majority of cases are infectious in nature, with enteroviruses being the primary causative agents [2].

Summary

In summary, Enteroviral vesicular pharyngitis (ICD-10 code B08.5) is marked by acute symptoms including fever, sore throat, headache, and oral vesicular lesions. It predominantly affects young children and is associated with specific seasonal patterns. The condition is primarily infectious, necessitating appropriate clinical management to alleviate symptoms and prevent complications.

The ICD-10 code B08.5, which refers to Enteroviral vesicular pharyngitis, is associated with several alternative names and related terms. Here are the key terms:

• Herpangina: This is a viral illness characterized by blister-like sores in the mouth and throat, which is specifically included under the definition of Enteroviral vesicular pharyngitis [8][9].
• Enteroviral vesicular stomatitis: This term is related and includes conditions like Hand, foot, and mouth disease, which are also associated with enteroviral infections [3][4].
• Other specified viral infections: B08.5 falls under a broader category that includes other specified viral infections characterized by skin and mucous membrane lesions [1][4].

These terms highlight the connections between Enteroviral vesicular pharyngitis and other viral illnesses, particularly those affecting the oral cavity and throat.

The diagnosis of Enteroviral vesicular pharyngitis, represented by the ICD-10 code B08.5, involves several criteria based on clinical presentation and examination findings. Here are the key diagnostic criteria:

• Symptoms: Patients typically present with a sore throat, which may be accompanied by difficulty swallowing (dysphagia) or pain on swallowing (odynophagia) [6][8].

• Physical Examination: The examination may reveal enlarged tonsils, which can be either with or without exudate. This is a common finding in cases of pharyngitis [8].

• Infectious Agents: The diagnosis is specifically related to infections caused by enteroviral agents, which are known to lead to vesicular lesions in the throat [6][10].

• Exclusion of Other Causes: It is important to differentiate Enteroviral vesicular pharyngitis from other types of pharyngitis, such as those caused by bacterial infections (e.g., streptococcal pharyngitis) or other viral agents [4][6].

• Clinical Context: The diagnosis is made within the context of the patient's overall clinical picture, including the presence of vesicular lesions and the absence of other more common causes of pharyngitis [6][10].

These criteria help healthcare providers accurately diagnose Enteroviral vesicular pharyngitis and ensure appropriate treatment and management.

The standard treatment approaches for Enteroviral vesicular pharyngitis, designated by ICD-10 code B08.5, primarily focus on symptomatic relief. Here are the key points regarding treatment:

• Symptomatic Relief: The main goal of treatment is to alleviate symptoms. This may include the use of pain relievers, throat lozenges, and hydration to soothe the throat and reduce discomfort [2].

• Antibiotics: Antibiotics are generally not indicated unless there is a confirmed or highly suspected bacterial infection. If antibiotics are prescribed, it is crucial for patients to complete the full course of therapy, regardless of symptom improvement, as they are typically noninfectious after 24 hours of antibiotic treatment [4].

• Intravenous Immunoglobulin Therapy: In cases of severe disease, intravenous immunoglobulin therapy may be considered, although further research is needed to establish its efficacy [7].

• Preventive Measures: Preventive strategies, particularly for conditions like hand-foot-and-mouth disease, may also be relevant, as enteroviral infections can be associated with such conditions [7].

Overall, the treatment is supportive, focusing on managing symptoms while monitoring for any potential complications that may require more intensive intervention.

ICD-10 code B08.5 refers to Enteroviral vesicular pharyngitis, which is a viral infection characterized by the presence of vesicular lesions in the pharynx. Here are the key clinical details and descriptions associated with this diagnosis:

• Definition: Enteroviral vesicular pharyngitis is primarily caused by enteroviruses and is often associated with herpangina, a condition that presents with painful sores in the throat and mouth [1][15].

• Symptoms: Patients typically experience:

• Sore throat
• Difficulty swallowing
• Fever

• Vesicular lesions in the throat and possibly on the soft palate [6][15].

• Transmission: The infection is contagious and can spread through direct contact with respiratory secretions or saliva from infected individuals. Close contact, especially in settings like schools or daycare centers, can facilitate outbreaks [15].

• Diagnosis: The diagnosis is made based on clinical presentation and may be supported by laboratory tests to identify the specific enterovirus responsible for the infection. The ICD-10 code B08.5 is used for billing and documentation purposes in healthcare settings [10][15].

• Treatment: There is no specific antiviral treatment for enteroviral infections. Management typically focuses on symptomatic relief, including:

• Pain relievers (e.g., acetaminophen or ibuprofen)
• Hydration

• Throat lozenges to soothe sore throat symptoms [15].

• Prognosis: The condition is generally self-limiting, with most patients recovering within a week to ten days without complications. However, severe cases may require medical attention, especially in young children or immunocompromised individuals [15].

This code is valid for use in the current fiscal year, specifically from October 1, 2024, through September 30, 2025, for the submission of HIPAA-covered transactions [1][10].